A detailed history of Somerset Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Somerset Trust CO holds 666 shares of LLY stock, worth $498,174. This represents 0.23% of its overall portfolio holdings.

Number of Shares
666
Previous 670 0.6%
Holding current value
$498,174
Previous $606,000 2.64%
% of portfolio
0.23%
Previous 0.25%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$772.14 - $960.02 $3,088 - $3,840
-4 Reduced 0.6%
666 $590,000
Q2 2024

Jul 09, 2024

BUY
$724.87 - $909.04 $70,312 - $88,176
97 Added 16.93%
670 $606,000
Q1 2024

Apr 05, 2024

SELL
$592.2 - $792.28 $2,368 - $3,169
-4 Reduced 0.69%
573 $445,000
Q4 2023

Jan 08, 2024

SELL
$525.19 - $619.13 $13,129 - $15,478
-25 Reduced 4.15%
577 $336,000
Q4 2022

Jan 03, 2023

BUY
$321.55 - $374.67 $193,573 - $225,551
602 New
602 $220,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Somerset Trust CO Portfolio

Follow Somerset Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Somerset Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Somerset Trust CO with notifications on news.